What Corbus Pharmaceuticals Holdings, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 1 | 3 |
| Sells | 3 | 13 |
| Total trades | 5 | 28 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 30,029 |
| Net activity | +0 | −30,029 |
Common stock only — 27 reported trades in the last 12 months are in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Ben Yong | Director | Sep 14 | Open-market sale · S | −2,000 | $7.84 | −$15.7K | 9,383 |
| Nicacio Leonardo Viana | Chief Medical Officer | Aug 16 | Grant / award · A | +58,333 | — | — | 58,333 |
| Saxena Nishant C | Chief Business Officer | Aug 11 | Open-market buy · P | +2,600 | $9.63 | +$25K | 77,900 |
| Moran Sean F. | Chief Financial Officer | Aug 07 | Open-market sale · S | −12,000 | $10.08 | −$121K | 84,694 |
| Cohen Yuval | Chief Executive Officer | Aug 07 | Open-market sale · S | −17,000 | $10.08 | −$171K | 157,316 |
| Jenkins John Kenneth | Director | Jun 10 | Open-market sale · S | −4,800 | $7.91 | −$38K | 3,833 |
| Altmeyer Anne | Director | Jun 10 | Open-market sale · S | −2,412 | $7.91 | −$19.1K | 7,579 |
| Kung Winston | Director | Jun 10 | Open-market sale · S | −2,026 | $7.91 | −$16K | 12,140 |
| Saxena Nishant C | Chief Business Officer | Jun 03 | Open-market buy · P | +9,000 | $7.58 | +$68.2K | 75,300 |
| Saxena Nishant C | Chief Business Officer | Jun 02 | Open-market buy · P | +4,500 | $7.33 | +$33K | 66,300 |
| Saxena Nishant C | Chief Business Officer | May 21 | Grant / award · A | +58,300 | — | — | 61,800 |
| Pfeiffenberger Brent | Director | May 19 | Grant / award · A | +7,500 | — | — | 7,500 |
| Jenkins John Kenneth | Director | May 19 | Grant / award · A | +3,800 | — | — | 8,633 |
| Altmeyer Anne | Director | May 19 | Grant / award · A | +3,800 | — | — | 9,991 |
| Ben Yong | Director | May 19 | Grant / award · A | +3,800 | — | — | 11,383 |
| Jacques Rachelle Suzanne | Director | May 19 | Grant / award · A | +3,800 | — | — | 11,383 |
| Kung Winston | Director | May 19 | Grant / award · A | +3,800 | — | — | 14,166 |
| Smethurst Dominic | Chief Medical Officer | Mar 02 | Open-market sale · S | −6,097 | $8.30 | −$50.6K | 89,790 |
| Hodgson Ian | Chief Operating Officer | Feb 17 | Open-market sale · S | −847 | $7.38 | −$6.25K | 51,080 |
| Moran Sean F. | Chief Financial Officer | Feb 13 | Open-market sale · S | −4,701 | $7.78 | −$36.6K | 96,694 |
Loading...
